In this work, we identified the most commonly mutated and copy number altered genes from the Pan-Cancer TCGA cohort (n = 9,104) and associated them with progression free survival (PFS) and disease specific survival (DSS) independently and after adjusting for TP53 mutations. This evidence concerns the gene TP53 and cancer.